Cannabis Law Report

DECEMBER 8, 2021

Global Psychiatry Partnering 2014 to 2021 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Access to headline, upfront, milestone and royalty data. Access to hundreds of Psychiatry deal contract documents. Specific therapy indication.

Access 52

Access Data Pharmaceutical Research and Development 52

The Joint Blog

NOVEMBER 4, 2019

The study found that 58% of physicians agree that “medical cannabis was a legitimate medical therapy.” ” The study concludes: “Providers generally believe that medical cannabis is a legitimate medical therapy. Healthcare providers play a critical role in facilitating patient access to medical cannabis.

Therapy 42

Therapy Clinical Trials Conditions Patients 42

Cannabis Law Report

SEPTEMBER 28, 2021

The TGA has approved the use of MDMA and Psilocybin to treat mental illness in Australia by qualified medical professionals under a special access scheme. The results of this survey cannot be shared with you, as the survey does not collect any contact details or personal information. Here’s the details on the research project.

Therapy 52

Therapy Medicine Data Collective 52

SpeedWeed

SEPTEMBER 17, 2021

million to assess the efficacy of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI). Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Veriheal

MAY 26, 2022

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. RoC also works to increase patients’ access to medical cannabis by helping U.S.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

OCTOBER 20, 2021

Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy. A Magical Future.

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

Veriheal

JUNE 30, 2023

Researchers say this emphasizes just how important it is that psilocybin therapy be done in a controlled setting with therapy and community-based after-care. The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

SEPTEMBER 10, 2021

is a pioneering Psychedelic Healthcare Innovation & Life Sciences Company in early stage development of Psilocybin (“Magic Mushroom”) based drugs and therapies proudly announces t he Filing of U. HENDERSON, Nev. , Sept. 9, 2021 /PRNewswire/ — PsiloThera, Inc.

Microdosing 98

Microdosing Research and Development Therapy Treatment 98

Cannabis Law Report

AUGUST 2, 2021

The diversified venture fund is focused on tackling the growing global mental health crisis by investing in innovative psychedelic-based and adjacent therapies that are poised to shape the future of psychiatry and fields beyond. Innovative psychedelic-based and adjacent therapies are poised to shape the future of psychiatry and fields beyond.

Research and Development 98

Research and Development Therapy Collective Treatment 98

Cannabis Law Report

NOVEMBER 3, 2021

This collectively brings the Company’s total clinic count to 15 globally. Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK.

Therapy 52

Therapy Access Patients Treatment 52

Veriheal

AUGUST 24, 2022

Activists collected over 100,000 more signatures than needed to qualify the measure for the ballot, showing significant support for its passing. In a statement to The Denver Post, Natural Medicine Colorado—which sponsored the act—said “the measure is designed to prioritize mental health and healing, while balancing safety and access.”

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

SEPTEMBER 2, 2021

The Contract contains no minimum testing requirement; it stipulates a fixed monthly fee for sample collection site services and a separate fixed fee per individual COVID-19 test. The initial Contract term is one year and includes two one-year options for renewal exercisable at the College’s discretion.

Clinical Trials 99

Clinical Trials Research and Development Therapy Collective 99

Cannabis Law Report

JANUARY 31, 2022

This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. These doses are produced under Good Agricultural and Collection Practices and tested for potency and impurities to support patient safety and practitioner confidence. investment community.”

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Veriheal

SEPTEMBER 23, 2021

Current statistics from the Anthenum Collective show that more than 67% of Americans believe cannabis should be legal, and legal cannabis sales are expected to achieve a value of $73.6 States that have legal access to medical and recreational cannabis often work with state-regulated insurers to obtain limited property and liability coverage.

Business 97

Business Access Cannabis Therapy 97

Cannabis Law Report

AUGUST 3, 2021

ADCL’s solution includes the use of subcontractor CLEARED4’s health verification platform for appointments, sample tracking, and value-add services of campus access management. As prime contractor, ADCL will also provide on-site staffing and sample transport and logistics.

Clinical Trials 105

Clinical Trials Therapy Collective Research and Development 105

Cannabis Law Report

DECEMBER 1, 2021

As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. Emma teaches classes on integrating kink-based consent practices into psychedelic-assisted therapy.

Safety 52

Safety Medicine Therapy Research and Development 52

MassRoots

FEBRUARY 17, 2019

Of the card-holding patients, more than 83,000 purchased products from a dispensary, and more than 600,000 transactions were collectively reported by the licensed dispensaries. Pennsylvania state lawmakers like Sen. “In Costa wrote on Twitter. Clearly, this was a serious need in the Commonwealth.”.

Marijuana 105

Marijuana Programs Dispensary Collective 105

Cannabis Law Report

JULY 28, 2021

This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies. The recent addition of KGK Science Inc. On behalf of: KETAMINE ONE.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

NORML

FEBRUARY 8, 2019

Activists in Mississippi have already collected thousands of signatures in hopes of qualifying a medical cannabis ballot initiative for the 2020 ballot. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. CT resident? CT resident? FL resident?

Legislation 172

Legislation Decriminalization Patients Access 172

Cannabis Law Report

NOVEMBER 5, 2021

Sample collection for weekly COVID-19 pooled testing can be performed in-person (supervised) or via self-collection kits 1. Negative testing results yield a ‘green pass’ via CLEARED4 that is texted to the employee’s smartphone that authorizes access to corporate facilities. Dr. James A. About Applied DNA Sciences.

Compliance 52

Compliance Compliance Research and Development Therapy 52

Cannabis Law Report

JULY 9, 2021

tonnes of cannabis that will be collected in the span of four years, with an annual harvest of 2.6 The company was founded in 2013 to provide patients, medical institutions, doctors, and pharmacists across Europe with access to safe and reliable cannabis-based medicine. euros per gram. The Federal Agency asked for a volume of 10.4

Cultivation 104

Cultivation Therapy Packaging Agriculture 104

Cannabis Law Report

JANUARY 4, 2022

Assay and Recently Developed, Unsupervised, At-Home Sample Collection Kit to Expand Addressable Market and Scope of COVID-19 Testing Services – STONY BROOK, N.Y.–(BUSINESS – Company Also Announces Intention to File Near-Term EUA Request with FDA for Linea 2.0 Assay (the “Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

JUNE 17, 2021

Silo Wellness is a publicly traded company on the CSE with a consumer-facing platform for the sale of functional mushroom products, psilocybin mushroom production in Jamaica, and the facilitation of psychedelic wellness retreats in both Jamaica and Oregon that incorporate a variety of psychedelic-augmented therapies. ir@silowellness.com.

Research and Development 75

Research and Development Access Therapy Media 75

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Medical marijuana requires a doctor’s recommendation and provides certain advantages, including lower taxes and access to a broader range of products.

Dispensary 52

Dispensary Patients Environment Conditions 52

Canna Law Blog

JULY 1, 2020

On June 29, the folks at “ Yes On IP 34 ” announced that the Psilocybin Therapy Initiative will qualify for the ballot this November in Oregon. The campaign said it had collected over 164,000 signatures and that its recent submission of additional signatures would comfortably put the initiative above the requirements.

Research and Development 59

Research and Development Therapy Education Conditions 59

Cannabis Law Report

JULY 9, 2021

The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” In a typical scenario, psychedelic substances would be used in conjunction with psychotherapy sessions to treat disorders for which other medicinal therapies have failed. Psychedelic therapy is not a fringe phenomenon.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives. .

Programs 100

Programs Data Events Collective 100

Veriheal

APRIL 25, 2022

Using all the existing information and that which they collected themselves, the researchers were able to confirm their hypothesis about lifetime use of MDMA/ecstasy, associating it with “decreased odds of past year suicidal thinking and planning.” Always consult a physician before attempting alternative therapies.

Treatment 104

Treatment Therapy Sleep Collective 104

Cannabis Cheri

APRIL 6, 2021

And a whole lot of what we do know about cannabis has come from people’s collective experiences with it, so we cannot discount that, especially since clinical research has been slow to catch up due to political interference blocking it for decades. One exception is cancer patients undergoing chemo-therapy. Enroll today!

Topical 246

Topical Marijuana Conditions Cannabinoids 246

Cannabis Law Report

JUNE 21, 2021

The talks will be made public, open-access on YouTube two weeks after the event. Dr. Stanislav Grof and Brigitte Grof – Stan Grof is the world’s leading researcher in psychedelic therapy, breathwork, and the exploration of non-ordinary states of consciousness, with wife and psychotherapist, Brigitte. Saturday, June 26, 2021.

Events 83

Events History Research and Development Therapy 83

Cannabis Law Report

OCTOBER 12, 2021

Mary Hartnett, Director of Medical Services at Sarah Lawrence College, stated, “safeCircle was our choice given the convenience of its on-site sample collection process, access to high-sensitivity RT-PCR-based testing with rapid turnaround times, ability to scale with our needs, and capacity to ease our administrative burdens.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

APRIL 11, 2022

Click on each link below to access the Eventbrite page of each course and read more about each: Diversity, Culture and Social Justice in Psychedelics. Workshop: Reducing the Impact of Bias on Therapy, Education, & Training. Includes access to all classes and a complimentary full year-long Chacruna membership .

Topical 52

Topical Education Therapy Access 52

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Veriheal

SEPTEMBER 21, 2021

include Beboe, Dogwalkers, Dr. Solomon’s, Incredibles, Rhythm, and The Feel Collection. This company’s market capitalization is $9.278 billion and is responsible for manufacturing and distributing cannabis in the medical and recreational markets. The cannabis brands from Green Thumb Industries Inc. Canopy Growth Corporation.

Recreational 104

Recreational Medicine Edibles Cannabis 104

Canna Law Blog

APRIL 13, 2019

These products have not been shown to be safe or effective, and deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”. Specifically, the agency fears that.

CBD 91

CBD Safety Topical Food 91

Canna Care Docs

OCTOBER 2, 2020

Approved patients will have access to over 80 dispensaries throughout the state and may purchase up to a 30 day supply at a time. To prepare for your appointment you will want to collect your medical records pertaining to the qualifying condition you wish to treat with Medical Cannabis.

Patients 52

Patients Therapy History Conditions 52